| abstract |
Described is the use of a (3-benzoylphenyl) alkanoic acid derivative applied to the gingiva of humans for the purpose of inhibiting the formation of endoperoxides, thromboxanes, leukotrienes, prostaglandins and related tissue-destructive end-products of arachidonic acid metabolism, for the prophylaxis or treatment of periodontal disease, preferably in a mucosal-tenacious vehicle which is selected from the groups of semi-solid pastes, gels, ointments, liquids or films. |